Literature DB >> 27687673

Practical synthesis of a phthalimide-based Cereblon ligand to enable PROTAC development.

Jasmin Lohbeck1, Aubry K Miller2.   

Abstract

The use of small molecules to regulate cellular levels of specific proteins is poised to become a powerful technique in the coming years. Critical to the success of any project utilizing such an approach will be the ability to synthesize libraries of candidate small molecules for testing in cellular systems. Herein, we describe a practical synthesis of a phthalimide-based scaffold, which can be easily diversified to make Cereblon-targeting PROTACs. We demonstrate the effectiveness of this approach by synthesizing a 'PROTAC toolbox' of four amines which can be coupled to inhibitors in a straightforward manner.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cereblon; E3 ligase; PROTACs; Thalidomide

Mesh:

Substances:

Year:  2016        PMID: 27687673     DOI: 10.1016/j.bmcl.2016.09.048

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

1.  A MedChem toolbox for cereblon-directed PROTACs.

Authors:  Christian Steinebach; Izidor Sosič; Stefanie Lindner; Aleša Bricelj; Franziska Kohl; Yuen Lam Dora Ng; Marius Monschke; Karl G Wagner; Jan Krönke; Michael Gütschow
Journal:  Medchemcomm       Date:  2019-05-28       Impact factor: 3.597

2.  Efficient Synthesis of Immunomodulatory Drug Analogues Enables Exploration of Structure-Degradation Relationships.

Authors:  George M Burslem; Philipp Ottis; Saul Jaime-Figueroa; Alicia Morgan; Philipp M Cromm; Momar Toure; Craig M Crews
Journal:  ChemMedChem       Date:  2018-07-04       Impact factor: 3.466

Review 3.  Cereblon: promise and challenges for combating human diseases.

Authors:  Hyoung Kyu Kim; Jung Eun Seol; Sang Woo Ahn; Seungje Jeon; Chul-Seung Park; Jin Han
Journal:  Pflugers Arch       Date:  2021-09-22       Impact factor: 3.657

4.  Traceless Staudinger ligation enabled parallel synthesis of proteolysis targeting chimera linker variants.

Authors:  Troy A Bemis; James J La Clair; Michael D Burkart
Journal:  Chem Commun (Camb)       Date:  2021-01-06       Impact factor: 6.222

Review 5.  Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway.

Authors:  Ian Collins; Hannah Wang; John J Caldwell; Raj Chopra
Journal:  Biochem J       Date:  2017-03-15       Impact factor: 3.857

6.  Synthesis and Chemiluminescent Properties of Amino-Acylated luminol Derivatives Bearing Phosphonium Cations.

Authors:  Anna Pantelia; Ira Daskalaki; M Consuelo Cuquerella; Georgios Rotas; Miguel A Miranda; Georgios C Vougioukalakis
Journal:  Molecules       Date:  2019-10-31       Impact factor: 4.411

Review 7.  E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points.

Authors:  Aleša Bricelj; Christian Steinebach; Robert Kuchta; Michael Gütschow; Izidor Sosič
Journal:  Front Chem       Date:  2021-07-05       Impact factor: 5.221

Review 8.  Degradation of proteins by PROTACs and other strategies.

Authors:  Yang Wang; Xueyang Jiang; Feng Feng; Wenyuan Liu; Haopeng Sun
Journal:  Acta Pharm Sin B       Date:  2019-08-13       Impact factor: 11.413

9.  PRosettaC: Rosetta Based Modeling of PROTAC Mediated Ternary Complexes.

Authors:  Daniel Zaidman; Jaime Prilusky; Nir London
Journal:  J Chem Inf Model       Date:  2020-10-06       Impact factor: 4.956

10.  Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766).

Authors:  Nicola E A Chessum; Swee Y Sharp; John J Caldwell; A Elisa Pasqua; Birgit Wilding; Giampiero Colombano; Ian Collins; Bugra Ozer; Meirion Richards; Martin Rowlands; Mark Stubbs; Rosemary Burke; P Craig McAndrew; Paul A Clarke; Paul Workman; Matthew D Cheeseman; Keith Jones
Journal:  J Med Chem       Date:  2018-01-05       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.